APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ceritinib

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ceritinib Industry Growth and Trends Forecast to 2032

23 December 202570 pages

Choose your research edition.

Industry ResearchCeritinib Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Ceritinib Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Ceritinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ceritinib Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ceritinib Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Ceritinib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ceritinib is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ceritinib is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ceritinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ceritinib include Lucius Pharmaceuticals, Natco and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ceritinib market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ceritinib market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ceritinib market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ceritinib.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ceritinib market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ceritinib Market by Company

Lucius Pharmaceuticals

Natco

Novartis

Ceritinib Segment by Type

90 Capsules/Box

50 Capsules/Box

150 Capsules/Box

Ceritinib Segment by Application

Clinic

Hospital

Pharmacy

Others

Ceritinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceritinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ceritinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceritinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ceritinib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ceritinib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 90 Capsules/Box Table 2. Major Company of 50 Capsules/Box Table 3. Major Company of 150 Capsules/Box Table 4. Global Ceritinib Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Ceritinib Sales by Type (2021-2026) & (k pcs) Table 6. Global Ceritinib Sales Market Share in Volume by Type (2021-2026) Table 7. Global Ceritinib Sales by Type (2021-2026) & (US$ Million) Table 8. Global Ceritinib Sales Market Share in Value by Type (2021-2026) Table 9. Global Ceritinib Price by Type (2021-2026) & (US$/pcs) Table 10. Global Ceritinib Sales by Type (2027-2032) & (k pcs) Table 11. Global Ceritinib Sales Market Share in Volume by Type (2027-2032) Table 12. Global Ceritinib Sales by Type (2027-2032) & (US$ Million) Table 13. Global Ceritinib Sales Market Share in Value by Type (2027-2032) Table 14. Global Ceritinib Price by Type (2027-2032) & (US$/pcs) Table 15. North America Ceritinib Sales by Type (2021-2026) & (k pcs) Table 16. North America Ceritinib Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Ceritinib Sales by Type (2021-2026) & (k pcs) Table 18. Europe Ceritinib Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Ceritinib Sales by Type (2021-2026) & (k pcs) Table 20. Asia-Pacific Ceritinib Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Ceritinib Sales by Type (2021-2026) & (k pcs) Table 22. Latin America Ceritinib Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Ceritinib Sales by Type (2021-2026) & (k pcs) Table 24. Middle East and Africa Ceritinib Sales by Type (2021-2026) & (US$ Million) Table 25. Ceritinib Industry Trends Table 26. Ceritinib Industry Drivers Table 27. Ceritinib Industry Opportunities and Challenges Table 28. Ceritinib Industry Restraints Table 29. Global Ceritinib Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Ceritinib Revenue Market Share by Company (2021-2026) Table 31. Global Ceritinib Sales by Company (2021-2026) & (k pcs) Table 32. Global Ceritinib Sales Share by Company (2021-2026) Table 33. Global Ceritinib Market Price by Company (2021-2026) & (US$/pcs) Table 34. Global Ceritinib Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Ceritinib Major Company Production Sites and Headquarters Table 36. Global Ceritinib Company, Product Type & Application Table 37. Global Ceritinib Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Ceritinib by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Ceritinib Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Ceritinib Sales by Region (2021-2026) & (k pcs) Table 42. Global Ceritinib Sales Market Share in Volume by Region (2021-2026) Table 43. Global Ceritinib Sales by Region (2021-2026) & (US$ Million) Table 44. Global Ceritinib Sales Market Share in Value by Region (2021-2026) Table 45. Global Ceritinib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 46. Global Ceritinib Sales by Region (2027-2032) & (k pcs) Table 47. Global Ceritinib Sales Market Share in Volume by Region (2027-2032) Table 48. Global Ceritinib Sales by Region (2027-2032) & (US$ Million) Table 49. Global Ceritinib Sales Market Share in Value by Region (2027-2032) Table 50. Global Ceritinib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2027-2032) Table 51. Global Ceritinib Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Ceritinib Sales by Application (2021-2026) & (k pcs) Table 53. Global Ceritinib Sales Market Share in Volume by Application (2021-2026) Table 54. Global Ceritinib Sales by Application (2021-2026) & (US$ Million) Table 55. Global Ceritinib Sales Market Share in Value by Application (2021-2026) Table 56. Global Ceritinib Price by Application (2021-2026) & (US$/pcs) Table 57. Global Ceritinib Sales by Application (2027-2032) & (k pcs) Table 58. Global Ceritinib Sales Market Share in Volume by Application (2027-2032) Table 59. Global Ceritinib Sales by Application (2027-2032) & (US$ Million) Table 60. Global Ceritinib Sales Market Share in Value by Application (2027-2032) Table 61. Global Ceritinib Price by Application (2027-2032) & (US$/pcs) Table 62. North America Ceritinib Sales by Application (2021-2026) & (k pcs) Table 63. North America Ceritinib Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Ceritinib Sales by Application (2021-2026) & (k pcs) Table 65. Europe Ceritinib Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Ceritinib Sales by Application (2021-2026) & (k pcs) Table 67. Asia-Pacific Ceritinib Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Ceritinib Sales by Application (2021-2026) & (k pcs) Table 69. Latin America Ceritinib Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Ceritinib Sales by Application (2021-2026) & (k pcs) Table 71. Middle East and Africa Ceritinib Sales by Application (2021-2026) & (US$ Million) Table 72. Lucius Pharmaceuticals Company Information Table 73. Lucius Pharmaceuticals Business Overview Table 74. Lucius Pharmaceuticals Ceritinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 75. Lucius Pharmaceuticals Ceritinib Product Portfolio Table 76. Lucius Pharmaceuticals Recent Development Table 77. Natco Company Information Table 78. Natco Business Overview Table 79. Natco Ceritinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 80. Natco Ceritinib Product Portfolio Table 81. Natco Recent Development Table 82. Novartis Company Information Table 83. Novartis Business Overview Table 84. Novartis Ceritinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 85. Novartis Ceritinib Product Portfolio Table 86. Novartis Recent Development Table 87. North America Ceritinib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 88. North America Ceritinib Sales by Country (2021-2026) & (k pcs) Table 89. North America Ceritinib Sales Market Share by Country (2021-2026) Table 90. North America Ceritinib Sales Forecast by Country (2027-2032) & (k pcs) Table 91. North America Ceritinib Sales Market Share Forecast by Country (2027-2032) Table 92. North America Ceritinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 93. North America Ceritinib Market Size by Country (2021-2026) & (US$ Million) Table 94. North America Ceritinib Market Share by Country (2021-2026) Table 95. North America Ceritinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 96. North America Ceritinib Market Share Forecast by Country (2027-2032) Table 97. Europe Ceritinib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 98. Europe Ceritinib Sales by Country (2021-2026) & (k pcs) Table 99. Europe Ceritinib Sales Market Share by Country (2021-2026) Table 100. Europe Ceritinib Sales Forecast by Country (2027-2032) & (k pcs) Table 101. Europe Ceritinib Sales Market Share Forecast by Country (2027-2032) Table 102. Europe Ceritinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. Europe Ceritinib Market Size by Country (2021-2026) & (US$ Million) Table 104. Europe Ceritinib Market Share by Country (2021-2026) Table 105. Europe Ceritinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. Europe Ceritinib Market Share Forecast by Country (2027-2032) Table 107. Asia-Pacific Ceritinib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 108. Asia-Pacific Ceritinib Sales by Country (2021-2026) & (k pcs) Table 109. Asia-Pacific Ceritinib Sales Market Share by Country (2021-2026) Table 110. Asia-Pacific Ceritinib Sales Forecast by Country (2027-2032) & (k pcs) Table 111. Asia-Pacific Ceritinib Sales Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Ceritinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Ceritinib Market Size by Country (2021-2026) & (US$ Million) Table 114. Asia-Pacific Ceritinib Market Share by Country (2021-2026) Table 115. Asia-Pacific Ceritinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Asia-Pacific Ceritinib Market Share Forecast by Country (2027-2032) Table 117. Latin America Ceritinib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 118. Latin America Ceritinib Sales by Country (2021-2026) & (k pcs) Table 119. Latin America Ceritinib Sales Market Share by Country (2021-2026) Table 120. Latin America Ceritinib Sales Forecast by Country (2027-2032) & (k pcs) Table 121. Latin America Ceritinib Sales Market Share Forecast by Country (2027-2032) Table 122. Latin America Ceritinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Latin America Ceritinib Market Size by Country (2021-2026) & (US$ Million) Table 124. Latin America Ceritinib Market Share by Country (2021-2026) Table 125. Latin America Ceritinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Latin America Ceritinib Market Share Forecast by Country (2027-2032) Table 127. Middle East and Africa Ceritinib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 128. Middle East and Africa Ceritinib Sales by Country (2021-2026) & (k pcs) Table 129. Middle East and Africa Ceritinib Sales Market Share by Country (2021-2026) Table 130. Middle East and Africa Ceritinib Sales Forecast by Country (2027-2032) & (k pcs) Table 131. Middle East and Africa Ceritinib Sales Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Ceritinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Ceritinib Market Size by Country (2021-2026) & (US$ Million) Table 134. Middle East and Africa Ceritinib Market Share by Country (2021-2026) Table 135. Middle East and Africa Ceritinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Middle East and Africa Ceritinib Market Share Forecast by Country (2027-2032) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Ceritinib Distributors List Table 140. Ceritinib Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Ceritinib Image Figure 2. Global Ceritinib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ceritinib Market Size (2021-2032) & (US$ Million) Figure 4. Global Ceritinib Sales (2021-2032) & (k pcs) Figure 5. 90 Capsules/Box Image Figure 6. Global 90 Capsules/Box Sales YoY Growth (2021-2032) & (k pcs) Figure 7. 50 Capsules/Box Image Figure 8. Global 50 Capsules/Box Sales YoY Growth (2021-2032) & (k pcs) Figure 9. 150 Capsules/Box Image Figure 10. Global 150 Capsules/Box Sales YoY Growth (2021-2032) & (k pcs) Figure 11. Global Ceritinib Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Ceritinib Market Share by Type 2025 VS 2032 Figure 13. North America Ceritinib Sales Market Share in Volume by Type in 2025 Figure 14. North America Ceritinib Sales Market Share in Value by Type in 2025 Figure 15. Europe Ceritinib Sales Market Share in Volume by Type in 2025 Figure 16. Europe Ceritinib Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Ceritinib Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Ceritinib Sales Market Share in Value by Type in 2025 Figure 19. Latin America Ceritinib Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Ceritinib Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Ceritinib Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Ceritinib Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Ceritinib Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k pcs) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (k pcs) Figure 29. Pharmacy Image Figure 30. Global Pharmacy Sales YoY Growth (2021-2032) & (k pcs) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k pcs) Figure 33. Global Ceritinib Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Ceritinib Market Share by Application 2025 VS 2032 Figure 35. North America Ceritinib Sales Market Share in Volume by Application in 2025 Figure 36. North America Ceritinib Sales Market Share in Value by Application in 2025 Figure 37. Europe Ceritinib Sales Market Share in Volume by Application in 2025 Figure 38. Europe Ceritinib Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Ceritinib Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Ceritinib Sales Market Share in Value by Application in 2025 Figure 41. Latin America Ceritinib Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Ceritinib Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Ceritinib Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Ceritinib Sales Market Share in Value by Application in 2025 Figure 45. North America Ceritinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 46. North America Ceritinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Ceritinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Ceritinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Ceritinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 50. Europe Ceritinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Ceritinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Ceritinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Ceritinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 54. Asia-Pacific Ceritinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Ceritinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Ceritinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Ceritinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 58. Latin America Ceritinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Ceritinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Ceritinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Ceritinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 62. Middle East and Africa Ceritinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Ceritinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Ceritinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Ceritinib Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Ceritinib Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 90 Capsules/Box
  • 50 Capsules/Box
  • 150 Capsules/Box
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Lucius Pharmaceuticals
  • Natco
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ceritinib Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ceritinib Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ceritinib Market by Type
  6. 1.3.1 90 Capsules/Box
  7. 1.3.2 50 Capsules/Box
  8. 1.3.3 150 Capsules/Box
  9. 1.4 Global Ceritinib Market Size by Type
  10. 1.4.1 Global Ceritinib Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Ceritinib Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Ceritinib Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Ceritinib Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Ceritinib Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Ceritinib Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Ceritinib Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Ceritinib Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ceritinib Industry Trends
  2. 2.2 Ceritinib Industry Drivers
  3. 2.3 Ceritinib Industry Opportunities and Challenges
  4. 2.4 Ceritinib Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ceritinib Revenue (2021-2026)
  2. 3.2 Global Top Players by Ceritinib Sales (2021-2026)
  3. 3.3 Global Top Players by Ceritinib Price (2021-2026)
  4. 3.4 Global Ceritinib Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ceritinib Major Company Production Sites & Headquarters
  6. 3.6 Global Ceritinib Company, Product Type & Application
  7. 3.7 Global Ceritinib Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ceritinib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ceritinib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ceritinib Tier 1, Tier 2, and Tier 3
4 Ceritinib Regional Status and Outlook
  1. 4.1 Global Ceritinib Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ceritinib Historic Market Size by Region
  3. 4.2.1 Global Ceritinib Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ceritinib Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ceritinib Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ceritinib Forecasted Market Size by Region
  7. 4.3.1 Global Ceritinib Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ceritinib Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ceritinib Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ceritinib by Application
  1. 5.1 Ceritinib Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Ceritinib Market Size by Application
  7. 5.2.1 Global Ceritinib Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Ceritinib Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Ceritinib Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Ceritinib Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Ceritinib Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Ceritinib Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Ceritinib Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Ceritinib Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Lucius Pharmaceuticals
  2. 6.1.1 Lucius Pharmaceuticals Company Information
  3. 6.1.2 Lucius Pharmaceuticals Business Overview
  4. 6.1.3 Lucius Pharmaceuticals Ceritinib Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Lucius Pharmaceuticals Ceritinib Product Portfolio
  6. 6.1.5 Lucius Pharmaceuticals Recent Developments
  7. 6.2 Natco
  8. 6.2.1 Natco Company Information
  9. 6.2.2 Natco Business Overview
  10. 6.2.3 Natco Ceritinib Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Natco Ceritinib Product Portfolio
  12. 6.2.5 Natco Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Ceritinib Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Ceritinib Product Portfolio
  18. 6.3.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Ceritinib Sales by Country
  2. 7.1.1 North America Ceritinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ceritinib Sales by Country (2021-2026)
  4. 7.1.3 North America Ceritinib Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ceritinib Market Size by Country
  6. 7.2.1 North America Ceritinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ceritinib Market Size by Country (2021-2026)
  8. 7.2.3 North America Ceritinib Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ceritinib Sales by Country
  2. 8.1.1 Europe Ceritinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ceritinib Sales by Country (2021-2026)
  4. 8.1.3 Europe Ceritinib Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ceritinib Market Size by Country
  6. 8.2.1 Europe Ceritinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ceritinib Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ceritinib Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ceritinib Sales by Country
  2. 9.1.1 Asia-Pacific Ceritinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ceritinib Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ceritinib Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ceritinib Market Size by Country
  6. 9.2.1 Asia-Pacific Ceritinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ceritinib Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ceritinib Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ceritinib Sales by Country
  2. 10.1.1 South America Ceritinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ceritinib Sales by Country (2021-2026)
  4. 10.1.3 South America Ceritinib Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ceritinib Market Size by Country
  6. 10.2.1 South America Ceritinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ceritinib Market Size by Country (2021-2026)
  8. 10.2.3 South America Ceritinib Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ceritinib Sales by Country
  2. 11.1.1 Middle East and Africa Ceritinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ceritinib Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ceritinib Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ceritinib Market Size by Country
  6. 11.2.1 Middle East and Africa Ceritinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ceritinib Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ceritinib Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ceritinib Value Chain Analysis
  2. 12.1.1 Ceritinib Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ceritinib Production Mode & Process
  7. 12.2 Ceritinib Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ceritinib Distributors
  10. 12.2.3 Ceritinib Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst